Status:
ENROLLING_BY_INVITATION
Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community
Lead Sponsor:
Fanfan Zheng
Conditions:
Cognition
Diabetes Mellitus, Type 2
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Objective A growing body of evidence supports diabetes as a risk factor for cognitive decline. Diabetes is significantly associated with accelerated cognitive decline, poorer cognitive function, and m...
Eligibility Criteria
Inclusion
- with a clear diagnosis of diabetes (according to ICD-10 or DSM-criteria), fasting blood glucose≥6.1mmol/L, maintaining the original diabetes treatment strategy
- age ≥60 years old
- literate and able to use smart phone or tablet computer skillfully, with CAIDE dementia risk score \>9, but without a diagnosis of dementia (ICD-10 or DSM-dementia diagnostic criteria)
- have lived in the target community for at least 6 months and continue to live in the original community for the next 12 months
Exclusion
- Stroke or brain surgery in the previous 12 months
- Alcohol or drug abuse in the past 12 months
- Families, important people of participants in the study have concerns
- Live in the same household as a participant who has been randomly assigned
- Severe aphasia, physical disability, or any other factor that may prevent completion of neuropsychological testing
- Use of medications that may affect cognition, including sedatives, anxiolytics, hypnotics, nootropics, and cholinergic drugs; Refusing or not receiving cognitive training
- currently participating in another clinical trial.
Key Trial Info
Start Date :
October 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06524388
Start Date
October 29 2024
End Date
June 1 2027
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xihuangcun Hospital
Beijing, China, 100144